1. Home
  2. PCM vs VANI Comparison

PCM vs VANI Comparison

Compare PCM & VANI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo PCM Fund Inc.

PCM

PCM Fund Inc.

HOLD

Current Price

$5.62

Market Cap

82.0M

Sector

Finance

ML Signal

HOLD

Logo Vivani Medical Inc. (DE)

VANI

Vivani Medical Inc. (DE)

HOLD

Current Price

$1.18

Market Cap

100.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PCM
VANI
Founded
1993
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Trusts Except Educational Religious and Charitable
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
82.0M
100.0M
IPO Year
N/A
2014

Fundamental Metrics

Financial Performance
Metric
PCM
VANI
Price
$5.62
$1.18
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$3.50
AVG Volume (30 Days)
42.8K
187.0K
Earning Date
01-01-0001
05-14-2026
Dividend Yield
11.68%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$4,000,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$5.52
$0.92
52 Week High
$6.76
$1.92

Technical Indicators

Market Signals
Indicator
PCM
VANI
Relative Strength Index (RSI) 38.22 46.97
Support Level $5.52 $1.15
Resistance Level $6.15 $1.26
Average True Range (ATR) 0.12 0.07
MACD -0.02 -0.01
Stochastic Oscillator 5.00 26.13

Price Performance

Historical Comparison
PCM
VANI

About PCM PCM Fund Inc.

Pcm Fund Inc is a closed-end investment management company. Its investment objective is to seek current income as a primary focus and also capital appreciation. The Fund invests in agency-guaranteed mortgage-backed securities, private-label mortgage-backed securities, high-yield corporate debt securities, and commercial mortgage-backed securities.

About VANI Vivani Medical Inc. (DE)

Vivani Medical Inc is a clinical stage biopharmaceutical company which develops miniature, ultra long-acting subdermal drug implant candidates utilizing its proprietary NanoPortal technology, which is designed to enable reversible, ultra long-acting, near constant-rate delivery of a broad range of medicines to treat chronic diseases. Vivani uses this platform technology to develop, and potentially commercialize, drug implant candidates, alone or in collaboration with pharmaceutical company partners, to address causes of poor clinical outcomes in the treatment of chronic diseases, including medication non-adherence, drug tolerability and administration challenges faced by certain patients. It operates in two segments the Biopharm Division and Neurostimulation Division.

Share on Social Networks: